Condensed Consolidated Statement of Noncontrolling Interests and Equity - USD ($) $ in Thousands	Total	Series D Units	Redemption of Operating Partnership units for stock	Redemption of Operating Partnership units for cash	Redemption of Operating Partnership units for cash Series B Units	Noncontrolling Interest - Preferred Operating Partnership	Noncontrolling Interest - Preferred Operating Partnership Series D Units	Noncontrolling Interest - Preferred Operating Partnership Redemption of Operating Partnership units for stock	Noncontrolling Interest - Preferred Operating Partnership Redemption of Operating Partnership units for cash Series B Units	Noncontrolling Interest - Operating Partnership	Noncontrolling Interest - Operating Partnership Redemption of Operating Partnership units for stock	Noncontrolling Interest - Operating Partnership Redemption of Operating Partnership units for cash	Noncontrolling Interest - Other	Common Stock	Common Stock Redemption of Operating Partnership units for stock	Additional Paid-in Capital	Additional Paid-in Capital Redemption of Operating Partnership units for stock	Additional Paid-in Capital Redemption of Operating Partnership units for cash	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Balance, beginning of period at Dec. 31, 2020	$ 2,936,124					$ 172,052				$ 215,892			$ 401	$ 1,314		$ 3,000,458			$ (99,093)	$ (354,900)
Balance, beginning of period (in shares) at Dec. 31, 2020														131,357,961
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon the exercise of options (in shares)														56,722
Issuance of common stock upon the exercise of options	4,254															4,254
Issuance of common stock in connection with share based compensation (in shares)														89,793
Issuance of common stock in connection with share based compensation	3,652															3,652
Restricted stock grants cancelled (in shares)														(2,499)
Issuance of common stock, net of offering costs (in shares)														2,185,685
Issuance of common stock, net of offering costs	273,720													$ 22		273,698
Redemption of operating partnership units			$ 0								$ (193)						$ 193
Redemption of Operating Partnership units (in shares)															5,000
Noncontrolling interest in consolidated joint venture	(50)												(50)
Net income	215,501					3,680				8,828			(5)							202,998
Other comprehensive income	23,013					144				956									21,913
Distributions to Operating Partnership units held by noncontrolling interests	(9,025)					(3,224)				(5,801)
Dividends paid on common stock	(132,540)																			(132,540)
Balance, end of period at Mar. 31, 2021	3,314,649					172,652				219,682			346	$ 1,336		3,282,255			(77,180)	(284,442)
Balance, end of period (in shares) at Mar. 31, 2021														133,692,662
Balance, beginning of period at Dec. 31, 2020	2,936,124					172,052				215,892			401	$ 1,314		3,000,458			(99,093)	(354,900)
Balance, beginning of period (in shares) at Dec. 31, 2020														131,357,961
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	593,900
Balance, end of period at Sep. 30, 2021	3,382,875					170,248				220,591			274	$ 1,338		3,283,848			(64,155)	(229,269)
Balance, end of period (in shares) at Sep. 30, 2021														133,819,163
Balance, beginning of period at Mar. 31, 2021	3,314,649					172,652				219,682			346	$ 1,336		3,282,255			(77,180)	(284,442)
Balance, beginning of period (in shares) at Mar. 31, 2021														133,692,662
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with share based compensation (in shares)														44,990
Issuance of common stock in connection with share based compensation	4,983															4,983
Restricted stock grants cancelled (in shares)														(4,972)
Offering costs associated with previous stock issuance	(211)															(211)
Redemption of operating partnership units			0	$ (472)							(2,185)	$ (113)			$ 1		2,184	$ (359)
Redemption of Operating Partnership units (in shares)															58,429
Repayment of receivable with Operating Partnership units pledged as collateral	411									411
Noncontrolling interest in consolidated joint venture	150												150
Net income	178,579					3,438				7,190			3							167,948
Other comprehensive income	5,617					35				232									5,350
Distributions to Operating Partnership units held by noncontrolling interests	(8,974)					(3,223)				(5,751)
Dividends paid on common stock	(133,777)																			(133,777)
Balance, end of period at Jun. 30, 2021	3,360,955					172,902				219,466			499	$ 1,337		3,288,852			(71,830)	(250,271)
Balance, end of period (in shares) at Jun. 30, 2021														133,791,109
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon the exercise of options (in shares)														5,600
Issuance of common stock upon the exercise of options	318															318
Issuance of common stock in connection with share based compensation (in shares)														10,913
Issuance of common stock in connection with share based compensation	4,012															4,012
Restricted stock grants cancelled (in shares)														(4,582)
Issuance of common stock, net of offering costs	(151)															(151)
Redemption of operating partnership units			0								$ (34)						34
Redemption of Operating Partnership units (in shares)															858
Redemption of Preferred B Units in the Operating Partnership for stock			$ 0					$ (2,834)							$ 1		$ 2,833
Redemption of preferred B units in the Operating Partnership for stock (in shares)															15,265
Purchase of remaining equity interest in existing consolidated joint venture	(12,050)															(12,050)
Noncontrolling interest in consolidated joint venture													(225)
Net income	199,820					3,529				8,015										188,276
Other comprehensive income	8,055					50				330									7,675
Distributions to Operating Partnership units held by noncontrolling interests	(10,585)					(3,399)				(7,186)
Dividends paid on common stock	(167,274)																			(167,274)
Balance, end of period at Sep. 30, 2021	3,382,875					170,248				220,591			274	$ 1,338		3,283,848			(64,155)	(229,269)
Balance, end of period (in shares) at Sep. 30, 2021														133,819,163
Balance, beginning of period at Dec. 31, 2021	$ 3,785,976					259,110				410,053			317	$ 1,339		3,285,948			(42,546)	(128,245)
Balance, beginning of period (in shares) at Dec. 31, 2021	133,922,305													133,922,305
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with share based compensation (in shares)														142,784
Issuance of common stock in connection with share based compensation	$ 4,542															4,542
Restricted stock grants cancelled (in shares)														(779)
Redemption of operating partnership units				(2,672)	$ (3,375)				$ (3,375)			(829)						(1,843)
Issuance of common stock in conjunction with acquisitions	40,965													$ 4		40,961
Issuance of common stock in conjunction with acquisitions (in shares)														186,766
Net income	217,717					4,333				9,805										203,579
Other comprehensive income	51,649					313				2,333									49,003
Distributions to Operating Partnership units held by noncontrolling interests	(14,111)					(4,330)				(9,781)
Dividends paid on common stock	(202,527)																			(202,527)
Balance, end of period at Mar. 31, 2022	3,878,164					256,051				411,581			317	$ 1,343		3,329,608			6,457	(127,193)
Balance, end of period (in shares) at Mar. 31, 2022														134,251,076
Balance, beginning of period at Dec. 31, 2021	$ 3,785,976					259,110				410,053			317	$ 1,339		3,285,948			(42,546)	(128,245)
Balance, beginning of period (in shares) at Dec. 31, 2021	133,922,305													133,922,305
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Buyback of common stock, net of offering costs	$ (63,008)
Buyback of common stock, net of offering costs (in shares)	(381,786)
Net income	$ 701,677
Balance, end of period at Sep. 30, 2022	$ 4,069,298					261,494				556,578			655	$ 1,339		3,339,961			48,521	(139,250)
Balance, end of period (in shares) at Sep. 30, 2022	133,918,037													133,918,037
Balance, beginning of period at Mar. 31, 2022	$ 3,878,164					256,051				411,581			317	$ 1,343		3,329,608			6,457	(127,193)
Balance, beginning of period (in shares) at Mar. 31, 2022														134,251,076
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with share based compensation (in shares)														38,016
Issuance of common stock in connection with share based compensation	5,245															5,245
Restricted stock grants cancelled (in shares)														(7,122)
Issuance of noncontrolling interests in conjunction with business combinations	16,000	$ 6,000					$ 6,000			16,000
Redemption of operating partnership units				$ (832)	$ (1,125)				$ (1,125)			$ (296)						$ (536)
Buyback of common stock, net of offering costs	(63,008)													$ (4)						(63,004)
Buyback of common stock, net of offering costs (in shares)														(381,786)
Net income	247,834					4,491				11,213										232,130
Other comprehensive income	20,113					120				895									19,098
Distributions to Operating Partnership units held by noncontrolling interests	(14,127)					(4,306)				(9,821)
Dividends paid on common stock	(201,024)																			(201,024)
Balance, end of period at Jun. 30, 2022	3,893,240					261,231				429,572			317	$ 1,339		3,334,317			25,555	(159,091)
Balance, end of period (in shares) at Jun. 30, 2022														133,900,184
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with share based compensation (in shares)														19,654
Issuance of common stock in connection with share based compensation	5,644															5,644
Restricted stock grants cancelled (in shares)														(1,801)
Issuance of noncontrolling interests in conjunction with business combinations	125,000
Noncontrolling interest in consolidated joint venture	338												338
Net income	236,126					4,454				10,953										220,719
Other comprehensive income	24,222					145				1,111									22,966
Distributions to Operating Partnership units held by noncontrolling interests	(14,394)					(4,336)				(10,058)
Dividends paid on common stock	(200,878)																			(200,878)
Balance, end of period at Sep. 30, 2022	$ 4,069,298					$ 261,494				$ 556,578			$ 655	$ 1,339		$ 3,339,961			$ 48,521	$ (139,250)
Balance, end of period (in shares) at Sep. 30, 2022	133,918,037													133,918,037